Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.9360
+0.0327 (3.62%)
May 13, 2026, 1:49 PM EDT - Market open
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $82.63 million as of May 13, 2026. Its market cap has increased by 64.94% in one year.
Market Cap
82.63M
Enterprise Value
76.24M
1-Year Change
64.94%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $82.63M, a decrease of -8.41%. That is a compound annual growth rate of -2.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 79.74M | -5.97% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lifecore Biomedical | 168.79M |
| Cardiol Therapeutics | 149.79M |
| Assertio Holdings | 144.34M |
| Journey Medical | 136.65M |
| Cumberland Pharmaceuticals | 68.35M |
| SCYNEXIS | 65.47M |
| Incannex Healthcare | 63.30M |
| BGM Group | 48.42M |